Buy ELLANSÉ™

Ellanse™ is an advanced dermal filler based on polycaprolactone (PCL) microspheres suspended in a carboxymethylcellulose gel carrier. This innovative composition delivers immediate volume enhancement coupled with progressive collagen stimulation. 

The PCL microspheres create a supportive scaffold that triggers natural collagen production, resulting in both instant aesthetic improvements and long-term rejuvenation. When you buy Ellanse filler, you’re investing in a solution that addresses both immediate concerns and progressive skin quality enhancement.

Ellanse™ is clinically proven for facial contouring, volumization, and wrinkle correction. Medical professionals utilize this versatile dermal treatment for restoring lost facial volume, defining facial contours, and correcting age-related changes. Its applications include treating nasolabial folds, marionette lines, cheek enhancement, jawline definition, and overall skin rejuvenation. The product is also effective for scar revision and hand rejuvenation, providing natural-looking, long-lasting results.

When you shop for premium dermal fillers, Ellanse™ distinguishes itself through its collagen-stimulating properties and extended longevity. Unlike conventional fillers that add volume temporarily, Ellanse™ promotes sustainable rejuvenation through active collagen production. 

The brand offers exceptional duration benefits with results lasting from 1 to 4 years depending on the formulation. This extended efficacy reduces treatment frequency, proving cost-effective for both practitioners and patients while delivering natural-looking results that improve over time.

Ellanse™ products deliver tiered longevity to match specific clinical requirements: 

• Ellanse-S lasts 1 year
• Ellanse-M extends to 2 years
• Ellanse-L provides 3 years of correction
• Ellanse-E maintains results for up to 4 years

This strategic duration spectrum enables medical professionals to customize treatments according to each patient’s aesthetic goals and treatment preferences. The longevity stems from PCL microspheres’ controlled biodegradation process, which maintains volumization while stimulating collagen production. Patients typically observe enhanced results 3–6 months after treatment as newly formed collagen progressively refines and reinforces the initial volumizing effect.

Ellanse™ has an excellent safety profile supported by extensive clinical studies and regulatory approvals across multiple international markets. The PCL microspheres have been thoroughly evaluated for biocompatibility and demonstrate predictable bio-resorption patterns without migration concerns. 

Rigorous safety assessments have confirmed minimal immunogenic potential, making Ellanse™ suitable for a wide range of patients. As with all injectable fillers, treatment should only be performed by qualified medical professionals with a thorough understanding of facial anatomy and advanced injection techniques.

The product’s safety is further enhanced by its synthetic composition, eliminating cross-species contamination risks associated with some biological fillers. Comprehensive post-market surveillance data continues to validate the favorable risk-benefit profile established in pre-market clinical investigations. 

For optimal patient outcomes, the product is not recommended for patients with allergies to its components, pregnant or breastfeeding women, those with autoimmune disorders, or those with infected or inflamed skin at the treatment site.